Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14409
Articles
Company
Drug
HEC Pharma Overturns Patent Decision Against Novartis’ Gilenya
February 5, 2025
Company
Deals
Nerviano Medical Sciences Collaborates with Merck on PARP1 Inhibitor NMS-293
February 5, 2025
Company
Moderna’s CMO Expresses Eagerness to Bring mRNA Vaccines to China
February 5, 2025
Company
Drug
Novartis Faces Setback in US Patent Battle Over Multiple Sclerosis Drug Gilenya
February 5, 2025
Company
Deals
Sino Biopharmaceutical Licenses Lanifibranor for NASH Treatment from Inventiva
February 5, 2025
Company
Drug
Hengrui Medicine’s Dexmedetomidine Nasal Spray Gains Priority Review
February 5, 2025
Company
Deals
Menarini and OrigiMed Partner on Pan-Cancer Single-Cell Diagnostic Platform
February 5, 2025
Company
Deals
Jenscare Scientific Set for IPO to Fund Structural Heart Disease Solutions
February 5, 2025
Company
Deals
InnoCare Pharma’s IPO Raises $411M for Drug R&D and Platform Upgrade
February 5, 2025
Company
Drug
Humanwell’s Generic Clobazam Approved for Lennox-Gastaut Syndrome in China
August 26, 2025
Company
Deals
AIM Vaccine Plans IPO to Fund Vaccine R&D and Pipeline Expansion
February 5, 2025
Company
Drug
AstraZeneca and Merck’s Lynparza Receives New Approval in China
February 5, 2025
1
2
…
1,127
1,128
1,129
1,130
1,131
…
1,200
1,201
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?